baber/WOPTO huggingface dataset:
Patent AT-E260092-T1 (AT)
Inventor: SCHMID HANS W
IPC: A61K9/107
Filed: 1999-11-12
Granted: 2004-03-15
Abstract: The present invention relates to a composition comprising a nano-emulsion that contains 5-aminolevulinic acid as well as a carrier in an aqueous phase. This invention also relates to a pharmaceutical preparation containing this composition. The nano-emulsions of this type can be used in photodynamic therapy as well as in the photodiagnostic detection of proliferatives cells.
Patent AT-E308216-T1 (AT)
Inventor: KAUHANEN TIMO
IPC: H04M7/00
Filed: 1999-11-03
Granted: 2005-11-15
Abstract: A telecommunications system comprising an arrangement for controlling a multicall over a transmission path between a telecommunications network and a subscriber terminal. A multicall may have three different bearer configurations: each call of the multicall has a dedicated bearer, or one bearer is shared by all calls of the multicall, or the multicall has both dedicated and shared bearers. When a shared bearer is used, a user can have several independent calls in parallel, which have to alternate in using the bearer, or in some situations, use it simultaneously. The network is arranged to set up any new call in an existing multicall, according to a criterion, either by (i) setting up said new call on a new bearer, or (ii) setting up said new call on an existing bearer so that said existing bearer is shared by at least two calls.
Patent DE-04010435-T1 (DE)
Inventor: ARONHIME JUDITH
IPC: A61P25/22
Filed: 2001-04-24
Abstract: The present invention provides for novel polymorphs of zolpidem hemitartrate and the preparation of the polymorphs.
Patent DE-11876-T1 (DE)
IPC: B65B11/04
Filed: 1979-12-01
Abstract: An automatic packaging machine comprises a slide (13) vertically sliding along a stationary load bearing column (2) and provided with horizontal rails (105,106) wherealong a power driven carriage (107) is movable carrying a packaging foil web supply device (103) for laying a top horizontal sheet onto a parcel or pile (34) to be packaged.
Patent DE-612725-T1 (DE)
Inventor: ROSE PETER DALE
IPC: A23L17/60
Filed: 1994-02-04
Abstract: The invention provides a method for the solvent-extraction of  beta -carotene from an aqueous algal biomass suspension, whereby a vegetable oil which is immiscible with water is mixed with an aqueous biomass suspension, the biomass containing the  beta -carotene, to form a mixture of the organic phase and the aqueous suspension, whereby the  beta -carotene is caused to dissolve in the organic phase. This is followed by separation of the organic phase from the aqueous phase by passing the organic phase containing the dissolved beta -carotene through a semi-permeable membrane to effect microfiltration or ultrafiltration of the organic phase. The membrane is of a material which is hydrophobic and the organic phase is passed through the membrane with a pressure drop across the membrane which is lower than that which causes the aqueous phase to pass through the membrane.
Patent ES-2058043-T1 (ES)
Inventor: NADDEO RONALD CHARLES
IPC: D21H17/00
Filed: 1992-05-20
Abstract: A method is disclosed for the detackification of stickies in the production of recycled paper products containing secondary fibers. Oxygen is used to reduce the tackiness of stickies in secondary pulps, and optionally is used with alkali and/or detackification agents for optimum stickies control.
Patent ES-2108678-T1 (ES)
Inventor: GHESQUIERE DENIS
IPC: C08L67/00
Filed: 1997-03-17
Abstract: Polyol polyester is obtained by reaction between acid (A), containing at least one aliphatic or aromatic polyacid, with hydroxy composition (P2), containing at least one di-functional polyol, and second hydroxy composition (P3) containing at least one polyol with functionality ≥ 3. (P2) consists of monoethyleneglycol and (P3) contains at least 3 oxyalkylene groups with 2-4C alkylene oxide. Also claimed is a polyurethane foam, for use in car interiors, obtained by reaction of polyol polyester with polyisocyanate.
Patent CY-1106941-T1 (CY)
Inventor: GOVARI ASSAF
IPC: A61B19/00
Filed: 2007-10-19
Abstract: Apparatus for tracking an object includes a plurality of field generators, which generate electromagnetic fields at different, respective frequencies in a vicinity of the object, and a radio frequency (RF) driver, which radiates a RF driving field toward the object. A wireless transponder is fixed to the object. The transponder includes at least one sensor coil, in which a signal current flows responsive to the electromagnetic fields, and a power coil, which receives the RF driving field and conveys electrical energy from the driving field to power the transponder. The power coil also transmits an output signal responsive to the signal current to a signal receiver, which processes the signal to determine coordinates of the object. <IMAGE>
Patent CY-1110180-T1 (CY)
Title: Μεθοδος για τον καθαρισμο ή την παραγωγη μιας mage πρωτεϊνης
Inventor: CABEZON SILVA TERESA
IPC: C12N15/70
Filed: 2010-06-10
Abstract: Η παρούσα εφεύρεση αφορά νέες πρωτεΐνες και παρασκευή αυτών από την οικογένεια MAGE. Συγκεκριμένα, μια MAGE πρωτεΐνη που συντήκεται προς έναν ανοσολογικό συνεργάτη σύντηξης, όπως Λιποπρωτεΐνη D. Τέτοια αντιγόνα μπορεί να τυποποιούνται για να παρέχουν εμβόλια για τη θεραπεία μιας περιοχής όγκων. Παρέχονται επίσης νέες μέθοδοι καθαρισμού MAGE πρωτεϊνών.
Patent CY-1112963-T1 (CY)
Inventor: FOX MICHAEL
IPC: A61K9/48
Filed: 2011-12-12
Abstract: Pharmaceutical compositions that have excellent storage even though they include an active component that is susceptible to degradation in an acidic environment are disclosed. The stabilized pharmaceutical composition of the invention includes a ring-opened 7-substituted-,35-dihydroxyheptanoic or a ring opened 7-substituted-3,5-dihydroxyheptenoic acid, or a pharmaceutically acceptable salt thereof, as an component and a stabilizing effective amount of at least one amino-group containing polymeric compound or at least one amino-group containing polymeric compound, or combination thereof; wherein the stabilized pharmaceutical composition does not contain a stabilizing effective amount of another stabilizer of a combination of other stabilizers. The pharmaceutical composition may optionally include one or more pharmaceutically acceptable excipients such as a filler, a disintegrating agent and one or more lubricants such as magnesium stearate to aid compression where a tablet dosage form is desired.
Patent CY-1117362-T1 (CY)
Title: Αναλυση γονιδιακης δοσολογιας
Inventor: HUBER ANDREAS R
IPC: C12Q1/68
Filed: 2016-04-06
Abstract: Η παρούσα εφεύρεση σχετίζεται με μεθόδους ανίχνευσης της παρουσίας γενετικού πολυμορφισμού εντός δύο ή περισσότερων στενά συνδεδεμένων, ομόλογων γονιδίων, για παράδειγμα, α-θαλασσαιμίας, σε δείγμα χρησιμοποιώντας RT-PCR υποβάλλοντας το δείγμα σε ξεχωριστές αντιδράσεις ενίσχυσης χρησιμοποιώντας (a) ζεύγος πρόσθιων και αντίστροφων εκκινητών ειδικών για την περιοχή κεφαλής του καθενός από αυτά τα δύο ή περισσότερα στενά συνδεδεμένα, ομόλογα γονίδια και (b) ζεύγος πρόσθιων και αντίστροφων εκκινητών ειδικών για την περιοχή ουράς του καθενός από αυτά τα δύο ή περισσότερα στενά συνδεδεμένα, ομόλογα γονίδια• και ανίχνευση και ποσοτικοποίηση των προϊόντων ενίσχυσης συγκριτικά με προϊόν-μάρτυρα.
Patent CY-1118536-T1 (CY)
Title: Κεφαλοσπορινη που διαθετει ομαδα κατεχολης
Inventor: NISHITANI YASUHIRO
IPC: C07D519/06
Filed: 2016-11-16
Abstract: Η ένωση της παρούσας εφεύρεσης παρέχει ενώσεις Κεφέμης, οι οποίες διαθέτουν ένα ευρύ αντιμικροβιακό φάσμα και διαθέτουν ισχυρή αντιμικροβιακή δράση ενάντια σε αρνητικά κατά Gram βακτήρια που παράγουν βήτα-λακταμάση, ως εξής: μία ένωση του τύπου: ή ο εστέρας της, μία προστατευτική ένωση στην αμίνη πάνω στο δακτύλιο στην 7-πλευρική αλυσίδα, ένα φαρμακευτικώς αποδεκτό άλας, ή ένα επιδιαλυτωμένο σύμπλοκο αυτών.
Patent CY-1119452-T1 (CY)
Title: Μια μεθοδος παρασκευης 2-αιθοξυ-1-(2'-((υδροξυamino) ιμινομεθυλο) διφαινυλ-4-υλο) μεθυλο)-1η- βενζο (d) ιμιδαζολο-7-καρβοξυλικο οξυ και τους εστερες αυτου
Inventor: RADL STANISLAV
IPC: C07D235/26
Filed: 2016-11-23
Abstract: Μια μέθοδος παρασκευής 2- αίθοξυ-1- ((2'- ((υδροξυάμινο) ιμινομέθυλο) διφαίνυλ-4- υλο) μέθυλο)-1H- βένζο [d] ιμιδαζολο -7- καρβοξυλικού οξέος και εστέρες αυτών του τύπου I, όπου το R είναι είτε Η ή ένα (μη) διακλαδισμένο C1-C4 αλκύλιο, ArCH2, Ar2CH, ή Ar3C, όπου το Ar είναι ένα (μη)υποκατεστημένο φαινύλιο, τα βασικά ενδιάμεσα στοιχεία για τη σύνθεση του azilsartan, με την αντίδραση του αντίστοιχου νιτριλίου του τύπου IV να εκτελείται με υδατική υδροξυλαμίνη σε ένα πολικό απρωτικό διάλυμα, ή ένα μείγμα των εν λόγω διαλυτών.
Patent CY-1120581-T1 (CY)
Title: Ενωσεις και μεθοδοι χρησης τους
Inventor: LEMIEUX RENE M
IPC: C07D417/14
Filed: 2018-08-17
Abstract: Παρέχονται ενώσεις του τύπου (I), που μπορούν να αναστέλλουν γλουταμινάση. Παρέχονται επίσης συνθέσεις που περιλαμβάνουν αυτές τις ενώσεις και χρήσεις ως αναστολείς γλουταμινάσης για θεραπευτική αγωγή καρκίνων με αυτές.
Patent CY-1121238-T1 (CY)
Title: Παραγωγα παντοθενικου για την αντιμετωπιση νευρολογικων διαταραχων
Inventor: VAINO ANDREW
IPC: A61K31/661
Filed: 2019-02-05
Abstract: Η παρούσα φανέρωση σχετίζεται με παράγωγα παντοθενικού για την αντιμετώπιση νευρολογικών διαταραχών (όπως νευροεκφύλιση που σχετίζεται με την παντοθενική κινάση), φαρμακευτικές συνθέσεις που περιέχουν τέτοιες ενώσεις, και τη χρήση τους στην αντιμετώπιση νευρολογικοί διαταραχών.
Patent CY-1123713-T1 (CY)
Title: Διαταξη προστασιας απο υπερταση που περιλαμβανει πολλαπλα δισκια βαριστορ
Inventor: TAVCAR TINE
IPC: H01C7/102
Filed: 2020-10-29
Abstract: Μια διάταξη προστασίας από υπέρταση (100) περιλαμβάνει ένα πρώτο μέλος ηλεκτρόδιου (122), ένα σχήματος εμβόλου δεύτερο μέλος ηλεκτρόδιου (124) και μια μονάδα βαρίστορ (150). Η μονάδα βαρίστορ περιλαμβάνει: ένα πλήθος από δισκία βαρίστορ (152, 154, 156), που το καθένα συνίσταται από ένα υλικό βαρίστορ• και τουλάχιστον ένα ηλεκτρικά αγώγιμο μέλος αλληλοσύνδεσης (160, 162) που συνδέει τα δισκία βαρίστορ εν παραλλήλω ηλεκτρικά ανάμεσα στο πρώτο και το δεύτερο μέλος ηλεκτρόδιου. Τα δισκία βαρίστορ στοιβάζονται αξονικά ανάμεσα στο πρώτο και το δεύτερο ηλεκτρόδιο. Η μονάδα περαιτέρω περιλαμβάνει έναν παράγοντα ένωσης (164, 164') που ενώνει μεταξύ τους τουλάχιστον δύο από τα δισκία βαρίστορ στη μονάδα βαρίστορ.
Patent CY-1126043-T1 (CY)
Title: Ιατροτεχνολογικο συστημα και μεθοδος κατασκευης αυτου
Inventor: KONYA AHMET
IPC: A61B5/00
Filed: 2023-06-16
Abstract: Η εφεύρεση αποκαλύπτει ένα ιατροτεχνολογικό σύστημα (110). Το ιατροτεχνολογικό σύστημα (110) περιλαμβάνεια. ένα περίβλημα (112)·β. μια προσυναρμολογημένη λειτουργική μονάδα (118) που φέρεται εντός του περιβλήματος (112), η οποία προσυναρμολογημένη λειτουργική μονάδα (118) περιλαμβάνειβ1. έναν αναλυτικό αισθητήρα (120) για την ανίχνευση τουλάχιστον ενός αναλυτή σε ένα σωματικό υγρό ενός χρήστη'β2. μια μονάδα ηλεκτρονικών (126) ηλεκτρικά συνδεδεμένη με τον αναλυτικό αισθητήρα (120)' καιβ3. ένα εξάρτημα εισαγωγής (130) για την εισαγωγή του αναλυτικού αισθητήρα (120) μέσα σε έναν ιστό του σώματος του χρήστη-γ. τουλάχιστον ένα αφαιρούμενο προστατευτικό κάλυμμα (134) συνδεδεμένο με το περίβλημα (112), που καλύπτει την προσυναρμολογημένη λειτουργική μονάδα (118).
Patent HR-P20120593-T1 (HR)
Title: Drive system for a ship
Inventor: CLAUS-D CHRISTOPHEL
IPC: B63H23/24
Filed: 2012-07-17
Abstract: The system (1) has multiple propellers (2) arranged at drive shafts (3), and electric drives (4) whose redundant arrangement is arranged on each drive shaft. A redundant arrangement of generators (9) is attached to the redundant arrangement of the electric drives, where the electric drives and the generators are controlled individually by a control unit. The electric drives and the generators are selectively activated by a switching unit, where the generators are formed in an identical or different manner. The electric drives and the generators are separated from each other.
Patent SI-1332262-T1 (SI)
Title: Reinforcing mat for reinforced concrete
Inventor: RITTER KLAUS
IPC: E04C5/04
Filed: 2001-11-08
Abstract: The mat consists of longitudinal and transverse wires (2,5), welded together at the crossing points. It has two longitudinal edge wires (3,4) and two transverse looped wire ends. The longitudinal wires within the center area (Z) of the mat are at the same relative axial distance (a) and have the same cross-sectional surfaces. Edge areas on both longitudinal sides consist of a pair of parallel wedge wires (3,4) at a relative axial distance (c), which is smaller than the first axial distance. The axial distance (b) between the inner edge wire (3) and the neighboring wire (2) of the central area, is also larger than the first axial distance. The edge areas consist of edge loops (7). All wires are of warm-rolled material of high ductility, with even-numbered diameters, subjected to additional cold forming, pref. stretching.
Patent SI-1382789-T1 (SI)
Title: PVC frame structure
Inventor: ARDESI PAOLO
IPC: E06B9/04
Filed: 2003-07-10
Abstract: This invention refers to a metal frame structure covered in PVC, such as for example a blind, comprising a base (2), two vertical uprights (3-4) and a plate or bracket (8) fastened in a removable way by means of screws to the profile section (5) of base (2). The plate or bracket (8) features a stop (9) for connecting to the base profile section (2) and a vertical upright (10) on which is fitted a sleeve or bush (11) featuring a threaded through hole (12). The structure also features one or two or more crosspieces (14-15, etc.) for fitting between the vertical uprights (3 and 4) of the frame and featuring a housing (14') for accommodating and hiding the plate or bracket (8). <IMAGE>
Patent SI-1400215-T1 (SI)
Title: Laser pulmonary vein isolation apparatus
Inventor: SCHWARTZ YITZHACK
IPC: A61B18/22
Filed: 2003-09-16
Abstract: A catheter introduction apparatus provides an optical assembly for emission of laser light energy. In one application, the catheter and the optical assembly are introduced percutaneously, and transseptally advanced to the ostium of a pulmonary vein. An anchoring balloon is expanded to position a mirror near the ostium of the pulmonary vein, such that light energy is reflected and directed circumferentially around the ostium of the pulmonary vein when a laser light source is energized. A circumferential ablation lesion is thereby produced, which effectively blocks electrical propagation between the pulmonary vein and the left atrium. <IMAGE>
Patent SI-1514001-T1 (SI)
Title: Drive device
Inventor: SOMMER FRANK-UWE
IPC: E05F15/16
Filed: 2003-06-05
Abstract: The drive mechanism, e.g. for gates and garage doors etc., has a guide rail (3) in the direction of gate/door movement for a moving slide (4) with an electromotor to operate the gate/door. The motor has connections to the electrical power supply (12), fed in at one end (7,9) of the guide rail. The electrical connection is a plug (8) with a cable (11), which can be connected at either end of the guide rail.
Patent SI-1631251-T1 (SI)
Title: Delayed release tablet with defined core geometry
Inventor: VERGNAULT GUY
IPC: A61K9/28
Filed: 2004-04-23
Abstract: A tablet comprising a core containing an active agent, and a coating, the core being disposed within the coating such that the coating has a thickness about a longitudinal axis (X-Y) of about 4.85 to 4.95 mm. The position of the core within the coating dictating that the active agent is released rapidly after a lag time during which time no active agent is released.
Patent SI-1684792-T1 (SI)
Title: Pharmaceutical formulations for the sustained release of interleukins and therapeutic applications thereof
Inventor: BIGNON SOPHIE
IPC: A61K38/21
Filed: 2004-11-19
Abstract: A liquid pharmaceutical formulation (I) for prolonged release of interleukin(s) (IL) comprises a low viscosity aqueous colloidal suspension of submicron particles of water-soluble, biodegradable polymers (II) carrying hydrophobic groups, non-covalently associated with IL(s) and optionally other active agent(s), where on parenteral injection (I) forms a gelled depot for prolonging the duration of active agent release to more than 24 hours. A liquid pharmaceutical formulation (I) for prolonged release of interleukin(s) (IL) comprises a low viscosity aqueous colloidal suspension (with water as dispersion medium) based on submicron particles (SMP's) of water-soluble, biodegradable polymers (II) carrying hydrophobic groups (HG's), non-covalently associated with IL(s) and optionally other active agent(s). On parenteral injection, (I) forms a gelled depot in vivo (at least partially due to physiological proteins), controlling and prolonging the duration of active agent release to more than 24 hours. (I) is liquid under the injection conditions; at physiological temperature and/or pH; and/or in presence of physiological electrolytes at physiological concentrations and/or surfactant(s). Independent claims are included for: (1) a variant of (I) as described above, where the duration of release of active agents is not restricted but the concentration of (II) is sufficiently high to form a gelled depot in vivo in presence of protein(s) after parenteral injection; (2) novel derived products (preferably in powder or gel form), consisting of SMP's formed by non-covalent association of (II) and active agents as above and obtained from (I); and (3) methods of preparation of (I). ACTIVITY : Antiinflammatory; immunomodulator. MECHANISM OF ACTION : T-Lymphocyte activator; T-lymphocyte proliferation profieration inducer.
Patent SI-1586430-T1 (SI)
Title: Structural member of laminar wood
Inventor: FANKHAUSER URS
IPC: B32B21/04
Filed: 2005-02-14
Abstract: A supporting structure (1) with a number of wooden lamellae (6) glued together with a layer of adhesive (17) between each pair of lamellae, in which the adhesive in every layer (17) shows a yield point (fDK) which is lower than the flexural strength of the adjacent more highly-loaded lamella (6) : An independent claim is also included for an adhesive for use in (1), with a yield point (fDK) which is lower than the breaking point (fDB) (for compressive loads applied at right angles to the lamellae) of the adjacent lamella on the opposite side to the applied load.
Patent SI-1831699-T1 (SI)
Title: Determination of neutrophil gelatinase-associated lipocalin (ngal) as a diagnostic marker for renal disorders
Inventor: UTTENTHAL LARS OTTO
IPC: G01N33/00
Filed: 2005-12-20
Abstract: Methods for diagnosing renal disorders by measuring human neutrophil gelatinase-associated lipocalin (NGAL) are provided.
Patent SI-1788149-T1 (SI)
Title: Coated textile
Inventor: SAIZ CARLOS
IPC: B60R25/00
Filed: 2006-11-09
Abstract: The textile has continuous tracks (2, 3) that are made of an electrically conductive material deposited on a coating layer. The tracks are connected at an end by an electric bridge (4). The tracks form an electric resistance that is along a textile zone. The tracks are connected to a device (5) that is sensible to modification of the resistance formed by the tracks. The tracks define a continuous pattern forming undulations (10, 11) imbricated on each other. The undulations are remote from each other by a distance in the order of a decimeter.
Patent SI-1987200-T1 (SI)
Title: Sealing plate for railway rail clip anchoring device and sleeper manufacturing method
Inventor: COX STEPHEN JOHN
IPC: E01B3/00
Filed: 2007-02-21
Abstract: A sealing plate for use with a rail clip anchoring device having a head and a stem which extends from the head into a concrete sleeper when the anchoring device is in use, is adapted for extending over the underside of the head when the stem of the device is being set in a concrete sleeper, thereby to prevent ingress of concrete into the head of the device, and for being retained on the surface of the sleeper thereafter. A major face of the plate, which is uppermost when the sleeper is in use, is provided with at least one clip seat portion for receiving part of a rail clip. In a method of manufacturing a concrete sleeper with at least one embedded rail clip anchoring device, the floor of a mold, from which the sleeper is to be formed, is provided with an aperture through which the head of an anchoring device is inserted and before concrete is introduced into the mold the aperture is sealed off around its edges and around the underside of the head of the anchoring device by placing a sealing plate over the aperture on the floor of the mold, the plate overlapping and sealing around the edges of the aperture other than where the anchoring device is located and having a mating interface with the anchoring device such that a seal is formed therewith.
Patent SI-2197534-T1 (SI)
Title: Device with two rotatable permanent magnets for application to the head of a subject
Inventor: PHILLIPS JAMES WILLIAM
IPC: G16H20/70
Filed: 2008-09-24
Abstract: Described are methods, devices, and systems for a novel, inexpensive, easy to use therapy for treatment of anxiety. Described are methods and devices to treat anxiety that involves no medication. Methods and devices described herein use alternating magnetic fields to gently “tune” the brain and affect symptoms of anxiety.
Patent SI-2621873-T1 (SI)
Title: Method for generating an open-pore near-surface layer of a microporous, hydrophobic molded thermal insulation body and which is wettable with aqueous systems
Inventor: KRATEL GUNTER
IPC: C04B41/00
Filed: 2011-09-27
Abstract: The invention relates to a method for generating an open-pore near-surface layer of a microporous, hydrophobic molded thermal insulation body, said layer being wettable with aqueous systems, wherein a microporous, hydrophobic molded thermal insulation body a) is treated with a polar fluid that can be mixed with water, or b) is exposed to a brief temperature treatment. The invention further relates to a method for applying a layer from an aqueous system onto the surface of a microporous, hydrophobic molded thermal insulation body, wherein the microporous, hydrophobic molded thermal insulation body a) is treated with a polar fluid that can be mixed with water and is reacted in the damp state with an aqueous system, or b) is exposed to a brief temperature treatment and directly or after a time delay is reacted with an aqueous system.
Patent SI-2632300-T1 (SI)
Title: Cervical pillow for treatment of cervical spine diseases
Inventor: PHAM THI KIM LOAN
IPC: A61H1/00
Filed: 2011-08-10
Abstract: A cervical pillow for treatment of cervical spine diseases includes a padded member made of resilient materials such as foam, rubber, or cotton. The padded member has a rectangular flat bottom side, vertically flat left and right sides, a rounded front side, a thin back side, and a wavy top side that has a flat portion connecting to the front side, a slightly concave portion in the middle, and a very convex portion connecting to the back side. The cervical pillow further includes a nearly rectangular solid block made of high- strength materials such as plastic or compressed rubber. This solid block is embedded within the padded member along its back side and under the very convex portion of its top side.
Patent DE-3486474-T2 (DE)
Inventor: REDDY VEMURI B
IPC: C12P21/00
Filed: 1984-10-31
Granted: 2000-08-03
Abstract: A biologically active secreted protein composed of a plurality of subunits is prepared by a recombinant methodology. Each subunit is synthesized by a cell having an autonomously replicating expression vector i.e. a plasmid or virus containing heterologous DNA encoding for the subunit. The preferred host is a eukaryotic cell. The secreted protein is a hormone such as hCG, luteinizing hormone (LH), follicle stimulating hormone (FSH) or thyroid stimulating hormone (TSH).